Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Achilles Therapeutics plc (ACHL)

  • Technical Exchange News
  • March 21, 2025, 00:24 UTC
  • 60
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: Achilles Therapeutics plc - American Depositary Shares.

Comment Full text

Achilles Therapeutics plc (ACHL)

  • Technical Exchange News
  • March 21, 2025, 00:24 UTC
  • 54
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: Achilles Therapeutics plc - American Depositary Shares. New value: Achilles Therapeutics plc - American Depositary Shares.

Comment Full text

CareCloud Inc (CCLDP)

  • Technical Exchange News
  • March 21, 2025, 00:24 UTC
  • 58
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: CareCloud, Inc. - 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock.

Comment Full text

CareCloud Inc (CCLDP)

  • Technical Exchange News
  • March 21, 2025, 00:24 UTC
  • 59
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: CareCloud, Inc. - 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock.

Comment Full text

Windtree Therapeutics Inc. (WINT)

  • Technical Exchange News
  • March 20, 2025, 19:09 UTC
  • 57
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Syros Pharmaceuticals (SYRS)

  • Technical Exchange News
  • March 20, 2025, 07:29 UTC
  • 56
  • 0 comments

Syros Pharmaceuticals (SYRS) was removed from the list of traded instruments on NASDAQ exchange

Comment Full text

Syros Pharmaceuticals (SYRS)

  • Technical Exchange News
  • March 20, 2025, 07:09 UTC
  • 60
  • 0 comments

NASDAQ symbol attribute type Security_Name was changed. Previous value: Syros Pharmaceuticals, Inc. - Common Stock. New value: Syros Pharmaceuticals, Inc. - Common Stock.

Comment Full text

Syros Pharmaceuticals (SYRS)

  • Technical Exchange News
  • March 20, 2025, 07:09 UTC
  • 57
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: Syros Pharmaceuticals, Inc. - Common Stock.

Comment Full text

Syros Pharmaceuticals (SYRS)

  • Technical Exchange News
  • March 20, 2025, 07:09 UTC
  • 59
  • 0 comments

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: Syros Pharmaceuticals, Inc. - Common Stock.

Comment Full text

Venus Concept Inc (VERO)

  • Technical Exchange News
  • March 20, 2025, 02:03 UTC
  • 52
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text
  • Previous
  • 272
  • 273
  • 274
  • 275
  • 276
  • Next

Search

News categories

  • Technical Exchange News(11376)
  • Event(2872)
  • SEC News(206965)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(134811)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin